skills/legal/equity-term-sheet/SKILL.md
Drafts a U.S. equity financing term sheet for preferred stock rounds (Series A/B/C), structured as a non-binding framework with binding confidentiality, exclusivity, expenses, and governing-law carveouts. Covers economic terms, governance, investor rights, protective provisions, and closing conditions. Produces a document suitable for VC or PE investor negotiations. Use when drafting term sheets, structuring equity financings, negotiating investor rights, or preparing cap table pricing frameworks.
npx skillsauth add casemark/skills equity-term-sheetInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
3 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
Drafts a non-binding term sheet capturing economic, governance, and investor rights terms for a preferred stock financing, with binding carveouts for confidentiality, exclusivity, expenses, and governing law.
If any prerequisite is missing, pause and ask — do not assume or fill gaps.
Include: company legal name and state of incorporation, series designation, date, and lead investor legal name.
State explicitly at the top of the term sheet which provisions are binding:
| Binding | Non-Binding | |---|---| | Confidentiality | Economic terms | | Exclusivity / No-shop | Governance terms | | Expenses | Investor rights | | Governing law / venue | |
| Term | Drafting Notes | |---|---| | Amount raised | Dollar amount or range | | Pre-money valuation | Dollar amount | | Price per share | Pre-money ÷ fully diluted capitalization pre-financing | | Security | Series designation + convertible preferred stock | | Use of proceeds | General corporate purposes, R&D, sales expansion, etc. |
Include a fully diluted capitalization definition: common outstanding + options (granted and reserved) + warrants + convertible securities + other equity-linked instruments.
Draft each subsection with the client's chosen terms. Default positions noted below; depart when instructed.
Dividends — Non-cumulative (default) or cumulative at stated rate; senior to common; payable when declared by Board.
Liquidation preference — 1x original purchase price (default). Specify participating vs. non-participating. If participating, state whether capped. Waterfall: preferred first, then as-converted to common.
Conversion — Optional 1:1 into common at holder's option. Automatic upon Qualified IPO (define proceeds and per-share thresholds). Standard adjustments for splits, dividends, recapitalizations.
Anti-dilution — Broad-based weighted average (default). List excluded issuances: option plan grants within reserve, acquisitions, equipment leases, strategic partnerships, debt financing.
Protective actions (list as separate consent items):
Specify: board size, seat allocation (common holders / preferred holders / independent), initial directors or TBD, and whether observer rights are permitted (if so, define access and confidentiality).
| Right | Standard | |---|---| | Information rights | Annual audited, quarterly unaudited, monthly financials, annual budget | | Inspection rights | Reasonable access with notice | | Major investor threshold | Holder of ≥ [TBD]% or [TBD] shares Preferred | | Pro rata rights | Major investors may purchase pro rata in new issuances; exceptions for option plan grants, M&A consideration, debt/lease financings, strategic partnerships |
| Type | Key Terms | |---|---| | Demand | After [TBD] period; minimum size $[TBD]; limited number of demands | | Form S-3 | If eligible; shorter notice period | | Piggyback | Subject to underwriter cutback | | Expenses | Company pays, excluding underwriting discounts/commissions |
| Category | Include | |---|---| | Due diligence | Corporate, IP, financials, tax, litigation, contracts | | Definitive documents | SPA, A&R Charter, Investors' Rights Agreement, ROFR/Co-Sale Agreement, Voting Agreement | | Consents | Prior investors, lenders, key counterparties | | Target closing date | Specific date or TBD |
Expenses — Company reimburses lead investor legal fees up to $[TBD]; specify payable on close or regardless of close.
Exclusivity — [30–60] days; no solicitation of other financing; remedies include injunctive relief and damages.
Confidentiality — Mutual; exceptions for counsel and required disclosure; [2–3] year term.
Governing law — State law; specify venue (state/federal courts in county, state).
Company (CEO or authorized officer) and lead investor (Managing Director / GP).
[TBD][VERIFY] if uncertain[VERIFY] for anything unconfirmedKey changes from the original:
[VERIFY] mandate, attorney-review-required guidelinetools
Audits the complete in-scope medical-record universe in a litigation matter and produces an attorney-facing, Bates-cited analysis of treatment gaps, missing records or providers, baseline coverage, material billing or production mismatches, and complaint evolution. Use when asked to find missing medical records, analyze treatment gaps or first-care timing, identify absent providers, assess whether a production is complete, or prepare a records-request target list. Use medical-record-chronology instead when the primary request is a chronological clinical narrative.
development
Drafts a legally compliant Private Placement Memorandum for Regulation D offerings (Rule 506(b)/506(c)), covering full disclosure framework including risk factors, capitalization, securities terms, use of proceeds, and investor qualification requirements. Enforces SEC anti-fraud compliance under Section 10(b)/Rule 10b-5, blue sky law considerations, and accredited investor verification under Rule 501. Use this skill when drafting PPMs, offering memorandums, Reg D disclosure documents, or private offering circulars for issuers raising capital from sophisticated investors. Also trigger when the user mentions private placement disclosure, offering memorandum, Reg D fundraising, or accredited investor verification. Even if the user just says "PPM" or "draft our offering memo," use this skill.
data-ai
Generates structured privacy and data protection law briefings across US, EU, UK, and other jurisdictions. Organizes by jurisdiction with compliance deadlines, enforcement actions, and legislative changes. Use when preparing privacy law briefings, compliance updates, regulatory change summaries, or data protection landscape reviews.
testing
Generates structured summaries of prior art references for patent prosecution, validity analysis, and freedom-to-operate assessments. Maps disclosures to claim elements with precise citations. Use when summarizing prior art, analyzing patent landscapes, mapping references to claims, or preparing office action responses.